While the need for fresh, clean water creates enormous challenges, it also creates opportunities to develop and implement new technologies that can improve the efficacy and lower the cost of treating water.
The memo further states that patients must meet numerous other qualifications relating to clinical trials and not have certain serious diseases or conditions that would lower the implant's efficacy or the patient's likelihood of long-term survival.